The Latest Headlines at Enterprise Leader
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Receives Average Recommendation of “Hold” from Analysts
Cross Country Healthcare, Inc. (NASDAQ:CCRN – Get Free Report) has been given an average recommendation of “Hold” by the four brokerages that are covering the firm, Marketbeat Ratings reports. Four equities research... More of this article »
The Duckhorn Portfolio, Inc. (NYSE:NAPA) Receives Consensus Recommendation of “Hold” from Brokerages
Shares of The Duckhorn Portfolio, Inc. (NYSE:NAPA – Get Free Report) have earned a consensus recommendation of “Hold” from the seven research firms that are presently covering the company, Marketbeat Ratings reports.... More of this article »
Daniel Stanley Perotti Sells 16,481 Shares of PennyMac Financial Services, Inc. (NYSE:PFSI) Stock
PennyMac Financial Services, Inc. (NYSE:PFSI – Get Free Report) CFO Daniel Stanley Perotti sold 16,481 shares of PennyMac Financial Services stock in a transaction that occurred on Friday, December 20th. The shares were sold... More of this article »
Insider Selling: Photronics, Inc. (NASDAQ:PLAB) Director Sells 19,750 Shares of Stock
Photronics, Inc. (NASDAQ:PLAB – Get Free Report) Director Adam M. Lewis sold 19,750 shares of the firm’s stock in a transaction on Friday, December 20th. The shares were sold at an average price of $24.11, for a total transaction... More of this article »
Cineplex Inc. (TSE:CGX) Director Sarabjit Marwah Sells 1,500 Shares
Cineplex Inc. (TSE:CGX – Get Free Report) Director Sarabjit Marwah sold 1,500 shares of the company’s stock in a transaction on Monday, December 23rd. The stock was sold at an average price of C$12.27, for a total value... More of this article »
H&R Real Estate Investment Trust (TSE:HR.UN) Senior Officer Robyn Kestenberg Purchases 3,716 Shares
H&R Real Estate Investment Trust (TSE:HR.UN – Get Free Report) Senior Officer Robyn Kestenberg bought 3,716 shares of the firm’s stock in a transaction on Friday, December 20th. The stock was acquired at an average... More of this article »
Royal Bank of Canada (NYSE:RY) Receives Average Recommendation of “Buy” from Analysts
Shares of Royal Bank of Canada (NYSE:RY – Get Free Report) (TSE:RY) have received a consensus recommendation of “Buy” from the seven analysts that are presently covering the stock, MarketBeat reports. One equities... More of this article »
Ovid Therapeutics Inc. (NASDAQ:OVID) Receives $4.04 Consensus Price Target from Analysts
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, Marketbeat reports. Two research analysts... More of this article »
Brokerages Set Regulus Therapeutics Inc. (NASDAQ:RGLS) Target Price at $10.80
Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) has received an average recommendation of “Moderate Buy” from the six research firms that are currently covering the firm, MarketBeat.com reports. One analyst... More of this article »
Insider Buying: Strawberry Fields REIT, Inc. (NYSEAMERICAN:STRW) Director Purchases 9,800 Shares of Stock
Strawberry Fields REIT, Inc. (NYSEAMERICAN:STRW – Get Free Report) Director Michael Blisko purchased 9,800 shares of Strawberry Fields REIT stock in a transaction on Thursday, December 19th. The shares were purchased at an average... More of this article »
Liberty Latin America Ltd. (NASDAQ:LILAK) Director Acquires $198,331.80 in Stock
Liberty Latin America Ltd. (NASDAQ:LILAK – Get Free Report) Director Brendan J. Paddick bought 31,989 shares of the company’s stock in a transaction dated Thursday, December 19th. The stock was bought at an average cost... More of this article »
Brokerages Set bluebird bio, Inc. (NASDAQ:BLUE) Price Target at $49.14
Shares of bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) have been given a consensus recommendation of “Hold” by the ten research firms that are presently covering the stock, Marketbeat.com reports. Two investment... More of this article »
Enfusion, Inc. (NYSE:ENFN) Receives Consensus Rating of “Reduce” from Brokerages
Shares of Enfusion, Inc. (NYSE:ENFN – Get Free Report) have earned a consensus recommendation of “Reduce” from the six analysts that are presently covering the stock, MarketBeat Ratings reports. Three research analysts... More of this article »